Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Unilateral Cleft Lip Repair
NCT02958306Phase 2Terminated
- Sponsor
- Cairo University
- Start
- Dec 2016
- Primary completion
- Feb 2018
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous platelet-rich plasma in cleft lip (CL) (2 arms), sponsored by Cairo University. Primary endpoint: scar width at 6 months. Started Dec 2016; status: terminated.
02
Drugs
autologous platelet-rich plasma
03
Conditions
cleft lip (CL)
Beyond the preview
Go deeper on NCT02958306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02958306.